Subscribe to RSS
DOI: 10.1055/s-0039-1683841
2019 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles
Publication History
Publication Date:
03 April 2019 (online)
![](https://www.thieme-connect.de/media/sth/201903/lookinside/thumbnails/10-1055-s-0039-1683841_02640-1.jpg)
Welcome to the latest of our Eberhard F. Mammen award announcements. As noted previously,[1] [2] [3] Thieme, the publisher of Seminars in Thrombosis & Hemostasis (STH), has created the “Eberhard F. Mammen Excellence in Thrombosis and Hemostasis Awards” in honor of Eberhard Mammen ([Fig. 1]), and in recognition of his contribution to this field and to the journal that he both founded and steered for over three decades. These awards began in 2009, under two categories, “Most Popular Article Awards” and “Young Investigator Awards.” Accordingly, 2019 marks a 10-year anniversary of sorts. Current details and conditions of the award can be summarized as:
![](https://www.thieme-connect.de/media/sth/201903/thumbnails/10-1055-s-0039-1683841-i02640-1.jpg)
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)
-
Most popular article awards: Awarded to the authors of the most popular articles published in STH. The awards are determined by the Editor in Chief on the basis of user statistics from Thieme e-Journals from the preceding 2 years. Prefaces, Errata, Letters to the Editor, Editorials, and previous award winning articles are excluded from further consideration of these awards, which currently comprise of two categories—one for “Open Access” articles, and another for a “General Category.” There are two major cash prizes of US$1,000 for each category. In addition, winners of the “General Category” awards are granted “open access” status for these articles thereafter.
-
Young investigator awards: Best presentation or meeting abstract by a young investigator—as presented or delivered to an international or large regional meeting on a topic related to the fields of thrombosis and hemostasis, and whose subject matter is determined to be in the spirit of Dr. Mammen. Up to six cash prizes of US$1,000 in any year. There are some additional considerations and conditions for the award, and awardees are expected to prepare a review or other paper related to the topic of their presentation (or as otherwise agreed) for publication in STH. In general, previous award winners are excluded from a second award to enable more individuals to be recognized. After nominations are received, the awardees are selected by a vote of the Senior Editors of STH. Any potential conflicts of interest are managed by first identifying these, and then excluding those with potential conflicts from voting.
Further details of the awards and the award winners are posted online (<https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00000077>), and previous award winner announcements are also available in print.[4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19]
It is therefore with great pleasure that we would like to announce the latest winners of the 2019 Eberhard F. Mammen awards for the most popular articles from STH for the period of 2017 to 2018 inclusive. We will be announcing the 2019 Young Investigator Awards at a forthcoming opportunity.
-
References
- 1 Favaloro EJ. Editorial. Welcome to a special issue of Seminars in Thrombosis and Hemostasis—the closing issue for 2008. Semin Thromb Hemost 2008; 34 (08) 693-696
- 2 Favaloro EJ. A tribute to Eberhard F. Mammen, M.D. (1930-2008). Semin Thromb Hemost 2008; 34 (08) 703-707
- 3 Favaloro EJ. Editorial. Welcome to the first issue of Seminars in Thrombosis and Hemostasis for 2009. Semin Thromb Hemost 2009; 35: 1-2
- 4 Favaloro EJ. Editorial. Winners of the Inaugural Eberhard F. Mammen Award for Most Popular Article. Semin Thromb Hemost 2009; 35 (07) 587-590
- 5 Favaloro EJ. Editorial. 2009 Eberhard F. Mammen Young Investigator award winners. Semin Thromb Hemost 2010; 36: 469-470
- 6 Favaloro EJ. Winners of the 2010 Eberhard F. Mammen award for most popular article during 2008-2009. Semin Thromb Hemost 2010; 36 (07) 685-692
- 7 Favaloro EJ. 2011 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2011; 37 (05) 431-439
- 8 Favaloro EJ. 2012 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2012; 38: 425-432
- 9 Favaloro EJ. Eberhard F. Mammen award announcements. Semin Thromb Hemost 2013; 39: 567-574
- 10 Favaloro EJ. 2014 Eberhard F. Mammen award announcements: part I - Most Popular articles. Semin Thromb Hemost 2014; 40 (04) 407-412
- 11 Favaloro EJ. 2014 Eberhard F. Mammen award announcements: part II-Young Investigator awards. Semin Thromb Hemost 2014; 40 (07) 718-723
- 12 Favaloro EJ. 2015 Eberhard F. Mammen Award announcements: part I--Most Popular articles. Semin Thromb Hemost 2015; 41 (07) 673-679
- 13 Favaloro EJ. 2015 Eberhard F. Mammen Award announcements: part II-Young Investigator awards. Semin Thromb Hemost 2015; 41 (08) 809-815
- 14 Favaloro EJ. 2016 Eberhard F. Mammen Award announcements: part I - Most Popular articles. Semin Thromb Hemost 2016; 42 (04) 325-330
- 15 Favaloro EJ. 2016 Eberhard F. Mammen Award announcements: part II-Young Investigator awards. Semin Thromb Hemost 2017; 43 (03) 235-241
- 16 Favaloro EJ. 2017 Eberhard F. Mammen Award announcements: part I-Most Popular Articles. Semin Thromb Hemost 2017; 43 (04) 357-363
- 17 Favaloro EJ. 2017 Eberhard F. Mammen Award announcements: part II-Young Investigator awards. Semin Thromb Hemost 2018; 44 (02) 81-88
- 18 Favaloro EJ. 2018 Eberhard F. Mammen Award announcements: part I-Most Popular articles. Semin Thromb Hemost 2018; 44 (03) 185-192
- 19 Favaloro EJ. 2017 Eberhard F. Mammen Award announcements: part II-Young Investigator awards. Semin Thromb Hemost 2018; 44 (02) 81-88
- 20 Kell DB, Pretorius E. To what extent are the terminal stages of sepsis, septic shock, systemic inflammatory response syndrome, and multiple organ dysfunction syndrome actually driven by a prion/amyloid form of fibrin?. Semin Thromb Hemost 2018; 44 (03) 224-238
- 21 Chighizola CB, Raimondo MG, Meroni PL. Management of thrombotic antiphospholipid syndrome. Semin Thromb Hemost 2018; 44 (05) 419-426
- 22 Schulman S. Update on the treatment of venous thromboembolism. Semin Thromb Hemost 2016; 42 (08) 891-898
- 23 Elewa H, Ahmed D, Barnes GD. Triple oral antithrombotic therapy in atrial fibrillation and coronary artery stenting: searching for the best combination. Semin Thromb Hemost 2016; 42 (06) 662-670
- 24 Harenberg J. Development of new anticoagulants: present and future. Semin Thromb Hemost 2008; 34 (08) 779-793
- 25 Mannucci PM, Mancuso ME, Santagostino E, Franchini M. Innovative pharmacological therapies for the hemophilias not based on deficient factor replacement. Semin Thromb Hemost 2016; 42 (05) 526-532
- 26 Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost 2009; 35 (02) 189-203
- 27 Raskob GE, Angchaisuksiri P, Blanco AN. , et al; ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to global disease burden. Semin Thromb Hemost 2014; 40 (07) 724-735
- 28 Schreiber K, Breen K, Cohen H. , et al. HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: a multinational randomized controlled trial of hydroxychloroquine versus placebo in addition to standard treatment in pregnant women with antiphospholipid syndrome or antibodies. Semin Thromb Hemost 2017; 43 (06) 562-571
- 29 Tersteeg C, Fijnheer R, Pasterkamp G. , et al. Keeping von Willebrand factor under control: alternatives for ADAMTS13. Semin Thromb Hemost 2016; 42 (01) 9-17
- 30 Favaloro EJ, Pasalic L, Curnow J. Type 2M and type 2A von Willebrand disease: similar but different. Semin Thromb Hemost 2016; 42 (05) 483-497
- 31 Favaloro EJ. Clinical utility of the PFA-100. Semin Thromb Hemost 2008; 34 (08) 709-733
- 32 Demers M, Wagner DD. NETosis: a new factor in tumor progression and cancer-associated thrombosis. Semin Thromb Hemost 2014; 40 (03) 277-283
- 33 Bunimov N, Fuller N, Hayward CP. Genetic loci associated with platelet traits and platelet disorders. Semin Thromb Hemost 2013; 39 (03) 291-305
- 34 Batorova A, Jankovicova D, Morongova A. , et al. Inhibitors in severe hemophilia A: 25-year experience in Slovakia. Semin Thromb Hemost 2016; 42 (05) 550-562
- 35 Harenberg J, Du S, Krämer S, Weiss C, Krämer R, Wehling M. Patients' serum and urine as easily accessible samples for the measurement of non-vitamin K antagonist oral anticoagulants. Semin Thromb Hemost 2015; 41 (02) 228-236
- 36 Italiano Jr JE. Unraveling mechanisms that control platelet production. Semin Thromb Hemost 2013; 39 (01) 15-24
- 37 Wada H, Usui M, Sakuragawa N. Hemostatic abnormalities and liver diseases. Semin Thromb Hemost 2008; 34 (08) 772-778
- 38 Mammen EF. Sticky platelet syndrome. Semin Thromb Hemost 1999; 25 (04) 361-365
- 39 Lippi G, Favaloro EJ, Sanchis-Gomar F. Sudden cardiac and noncardiac death in sports: epidemiology, causes, pathogenesis, and prevention. Semin Thromb Hemost 2018; 44 (08) 780-786
- 40 Klil-Drori AJ, Tagalakis V. Direct oral anticoagulants in end-stage renal disease. Semin Thromb Hemost 2018; 44 (04) 353-363
- 41 Kitchen S, Tiefenbacher S, Gosselin R. Factor activity assays for monitoring extended half-life FVIII and factor IX replacement therapies. Semin Thromb Hemost 2017; 43 (03) 331-337
- 42 Reynen E, James P. Von Willebrand disease and pregnancy: a review of evidence and expert opinion. Semin Thromb Hemost 2016; 42 (07) 717-723
- 43 Thomas J, Kostousov V, Teruya J. Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation. Semin Thromb Hemost 2018; 44 (01) 20-29
- 44 Schreiber K, Hunt BJ. Pregnancy and antiphospholipid syndrome. Semin Thromb Hemost 2016; 42 (07) 780-788
- 45 Scharf RE. Drugs that affect platelet function. Semin Thromb Hemost 2012; 38 (08) 865-883
- 46 Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost 2004; 30 (05) 579-589
- 47 Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost 2003; 29 (05) 435-450
- 48 Marlar RA, Clement B, Gausman J. Activated partial thromboplastin time monitoring of unfractionated heparin therapy: issues and recommendations. Semin Thromb Hemost 2017; 43 (03) 253-260
- 49 McEwen BJ. The influence of herbal medicine on platelet function and coagulation: a narrative review. Semin Thromb Hemost 2015; 41 (03) 300-314
- 50 Douxfils J, Gosselin RC. Laboratory assessment of direct oral anticoagulants. Semin Thromb Hemost 2017; 43 (03) 277-290
- 51 Franchini M, Mannucci PM. The history of hemophilia. Semin Thromb Hemost 2014; 40 (05) 571-576
- 52 Bolliger D, Tanaka KA. Point-of-care coagulation testing in cardiac surgery. Semin Thromb Hemost 2017; 43 (04) 386-396
- 53 Van Cott EM, Roberts AJ, Dager WE. Laboratory monitoring of parenteral direct thrombin inhibitors. Semin Thromb Hemost 2017; 43 (03) 270-276
- 54 Walsh M, Shreve J, Thomas S. , et al. Fibrinolysis in trauma: “myth,” “reality,” or “something in between”. Semin Thromb Hemost 2017; 43 (02) 200-212
- 55 Davie EW, Kulman JD. An overview of the structure and function of thrombin. Semin Thromb Hemost 2006; 32 (Suppl. 01) 3-15
- 56 Scully M. Thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome microangiopathy in pregnancy. Semin Thromb Hemost 2016; 42 (07) 774-779
- 57 Cohen H, Efthymiou M, Gates C, Isenberg D. Direct oral anticoagulants for thromboprophylaxis in patients with antiphospholipid syndrome. Semin Thromb Hemost 2018; 44 (05) 427-438
- 58 Gall LS, Brohi K, Davenport RA. Diagnosis and treatment of hyperfibrinolysis in trauma (a European perspective). Semin Thromb Hemost 2017; 43 (02) 224-234
- 59 Babin JL, Traylor KL, Witt DM. Laboratory monitoring of low-molecular-weight heparin and fondaparinux. Semin Thromb Hemost 2017; 43 (03) 261-269
- 60 Favaloro EJ. A tribute to Eberhard F. Mammen, M.D. (1930-2008). Semin Thromb Hemost 2008; 34 (08) 703-707
- 61 Favaloro EJ. Hot topics V. Semin Thromb Hemost 2014; 40 (01) 5-10
- 62 Othman M, McLintock C, Kadir R. Thrombosis and hemostasis related issues in women and pregnancy. Semin Thromb Hemost 2016; 42 (07) 693-695
- 63 Kwaan H, Lisman T, Medcalf RL. Fibrinolysis: biochemistry, clinical aspects, and therapeutic potential. Semin Thromb Hemost 2017; 43 (02) 113-114
- 64 Adcock DM, Gosselin RC. Laboratory assessment of hemostatic and anticoagulant therapy. Semin Thromb Hemost 2017; 43 (03) 242-244
- 65 Mammen EF, Comp PC, Gosselin R. , et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998; 24 (02) 195-202
- 66 Favaloro EJ. A short history of thrombosis and hemostasis: part I (40th year celebratory issue). Semin Thromb Hemost 2014; 40 (05) 521-525
- 67 Favaloro EJ. A short history of thrombosis and hemostasis: part II (40th year celebratory issue). Semin Thromb Hemost 2014; 40 (08) 826-830
- 68 Kubisz P, Stasko J, Holly P. Sticky platelet syndrome. Semin Thromb Hemost 2013; 39 (06) 674-683
- 69 Kubisz P, Ruiz-Argüelles GJ, Stasko J, Holly P, Ruiz-Delgado GJ. Sticky platelet syndrome: history and future perspectives. Semin Thromb Hemost 2014; 40 (05) 526-534
- 70 Sokol J, Biringer K, Skerenova M, Stasko J, Kubisz P, Danko J. Different models of inheritance in selected genes in patients with sticky platelet syndrome and fetal loss. Semin Thromb Hemost 2015; 41 (03) 330-335
- 71 Sokol J, Skerenova M, Jedinakova Z. , et al. Progress in the understanding of sticky platelet syndrome. Semin Thromb Hemost 2017; 43 (01) 8-13
- 72 Kubisz P, Holly P, Stasko J. Sticky platelet syndrome – 35 years of growing evidence. Semin Thromb Hemost 2019; 45 (01) 61-68